StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
USNA$18.33-2.13%
Fair $18.33+0.0%

USNA

USANA Health Sciences, Inc.

Consumer Defensive / Packaged FoodsNYSE

$18.33

-0.39 (-2.13%)

Fairly Valued+0.0%Fair Value $18.33Fund rank 29/100 · Data gapFallback financials|
SA 12/F
F-Score: 4/9
Margin CompressionLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF $8.5M · quality 48.7/100

Data gap 29/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 49/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

12/100

F

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

20/100

SEC 0%

Latest source: unknownPeriods: 15Warnings: 2unknown: 15
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Operating margin has declined for 5 consecutive years ROE is 2.0%, below the 5% threshold
Thesis & Journal · USNALocal privado en este navegador · USANA Health Sciences, Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$338M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

2.0%

↓

Gross Margin

78.3%

↑

Debt/Equity

N/A

•
52-Week Range$18
$17$38

TradingView lightweight chart

USNA price, volumen y niveles de valoración

Último $18.33Periodo +1443.6%
Fair value: $18.33

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2010–2026 · 16 años de histórico normalizado

Revenue CAGR

—

FCF CAGR

-7.2%

FCF margin

0.9%

FCF / Net income

0.79x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $925.3M · net income $10.8M · FCF $8.5M

2010-FY → 2026-FY

Gross margin

78.3%— pts

Operating margin

4.0%— pts

Net margin

1.2%— pts

FCF margin

0.9%— pts
MetricTTM
2026
2025
2024
2023
2022
2021
2019
2018
2017
2016
2015
2013
2012
2011
2010
Income Statement
Revenue$925.3M$925.3M$925.3M$854.5M$921.0M$998.6M$1.13B$1.06B$1.19B$1.05B$1.01B—————
Net Income$10.8M$10.8M$10.8M$42.0M$63.8M$69.3M$124.7M$100.5M$126.2M$62.5M$100.0M$76.6M$79.0M$66.4M$50.8M$33.6M
EBITDA$70.0M$70.0M$82.1M$98.9M$123.1M$130.2M$190.2M$160.9M$205.2M$148.6M$152.1M$124.9M$125.8M$107.0M$85.7M$57.9M
EPS0.580.580.582.193.303.595.864.415.122.533.992.802.782.231.631.08
Gross Margin78.3%78.3%78.3%81.1%80.8%80.6%81.6%82.3%83.1%82.9%82.1%—————
Operating Margin4.0%4.0%5.5%7.8%10.1%10.8%15.6%13.8%15.8%12.7%13.8%—————
Net Margin1.2%1.2%1.2%4.9%6.9%6.9%11.0%9.5%10.6%6.0%9.9%—————
Balance Sheet
Debt/Equity——0.040.050.020.02——————————
Current Ratio——2.51—————————————
Cash Flow
Free Cash Flow$8.5M$8.5M$8.5M$50.9M$56.1M$93.5M$145.3M$110.2M$140.7M$110.6M$104.2M$84.8M$90.8M$84.4M$59.5M$28.3M
Returns
ROE2.0%2.0%2.0%7.9%12.8%16.0%28.2%28.6%32.3%17.2%30.8%33.3%30.3%35.8%29.2%45.1%
Valuation
P/E——35.8816.5215.3415.56——————————
EV/EBITDA——2.375.475.336.12——————————
P/B——0.631.301.972.48——————————
Growth & Yield
Revenue Growth8.3%8.3%8.3%-7.2%-7.8%—7.0%-10.8%13.6%4.1%——————
EPS Growth-73.5%-73.5%-73.5%-33.6%-8.1%—32.9%-13.9%102.4%-36.6%42.5%0.7%24.9%36.5%50.2%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

41.0%

muy exigente

EPS terminal req.

$1.63

Spread vs growth

-114.5%

5Y implied EPS CAGR

27.7%

muy exigente

EPS terminal req.

$1.97

Spread vs growth

-101.2%

10Y implied EPS CAGR

18.5%

exigente

EPS terminal req.

$3.17

Spread vs growth

-92.0%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -38.6%

Total return

-38.6%

Start / end P/E

50.4x → 30.9x

EPS bridge

0.58 → 0.58

Residual

+0.0%

EPS growth+0.0%
Multiple rerating-38.6%
Dividend+0.0%
Residual / FX / buybacks / cross-term+0.0%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.